Surgeon-Anesthesiologist Collaboration (CCAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03158870
Recruitment Status : Not yet recruiting
First Posted : May 18, 2017
Last Update Posted : May 18, 2017
Information provided by (Responsible Party):
Hospices Civils de Lyon

Brief Summary:
Collaboration between the surgeon and the anesthesiologist is key for delivering a safe pheochromocytoma surgery. This study aims to establish the collective performance of surgeon-anesthesiologist team by quantifying the relationship between their previous collaborations and patient complications.

Condition or disease Intervention/treatment
Pheochromocytoma Collaboration Procedure: Surgery complications

Study Type : Observational
Estimated Enrollment : 1122 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Influence of Surgeon-anesthesiologist Collaboration on Patient Outcomes After Pheochromocytoma Surgery
Estimated Study Start Date : July 2017
Estimated Primary Completion Date : December 2017
Estimated Study Completion Date : December 2017

Group/Cohort Intervention/treatment
Patient who underwent surgical procedure for pheochromocytoma
Procedure: Surgery complications
Assessment of the influence of surgeon-anesthesiologist collaboration on surgery complications during and up to 30 days after pheochromocytoma surgery.

Primary Outcome Measures :
  1. Presence of an intraoperative hemodynamic instability [ Time Frame: At the time of surgery (less than 4 hours) ]
    An intraoperative hemodynamic instability is defined as the occurrence of at least one intraoperative episode of systolic blood pressure ≥ 160 mmHg and at least one episode of mean blood pressure ≤ 60 mmHg

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
Patients operated for pheochromocytoma

Inclusion Criteria:

  • All patients who underwent surgical procedure for pheochromocytoma in 8 French university hospitals from January 2000 to December 2016

Exclusion Criteria:

  • Age < 18 years old
  • Patients operated for incidentaloma or with paraganglioma diagnosis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT03158870

Contact: Jean-Christophe LIFANTE, MD, PhD 04 78 56 90 95 ext +33
Contact: Antoine DUCLOS, MD, PhD 04 72 11 51 66 ext +33

Pôle Information Médicale Evaluation Recherche des Hospices Civils de Lyon - Centre Hospitalier Lyon Sud
Pierre-Bénite, France, 69495
Sponsors and Collaborators
Hospices Civils de Lyon

Responsible Party: Hospices Civils de Lyon Identifier: NCT03158870     History of Changes
Other Study ID Numbers: 69HCL17_0030
First Posted: May 18, 2017    Key Record Dates
Last Update Posted: May 18, 2017
Last Verified: May 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Neuroendocrine Tumors
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms, Nerve Tissue